I was reading the phase II results and found them very interesting. It looked, at a glance, like there is clinical benefit for about 2 weeks, however when the effect of the cells wears off the body is not producing whatever combo it is that is slowing progression? Anyway, I was hoping they would dose less cells more often. But the three doses looks quite interesting as well. The 2-3 years suggested to finish phase III looks quite trim to me.